Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Placing

10 Aug 2009 07:00

RNS Number : 1293X
Imaginatik PLC
10 August 2009
 



10 August 2009

Imaginatik plc

("Imaginatik" or the "Company")

Placing to raise approximately £1.576 million

Imaginatik plc (AIM: IMTK), a leading provider of enterprise collaborative software and processes, announces that it has conditionally raised approximately £1.576 million through a placing of 26,266,666 new ordinary shares of 0.0625p each (the "Placing Shares") at a price of pence per share (the "Placing"). The Company intends that the net proceeds of the Placing will be used to provide the Company with the resources to pursue its growth plans and for general working capital purposes.

The Placing Shares have been conditionally placed by Arbuthnot Securities Limited ("Arbuthnot") with institutional and other investors. Application will be made to London Stock Exchange plc for the Placing Shares to be admitted to trading on AIM. Subject, inter alia, to admission of the Placing Shares to AIM becoming effective, dealings in the Placing Shares are expected to commence on AIM at 8.00 a.m. on 13 August 2009. The Placing Shares represent approximately 20 per cent. of the Company's existing issued share capital and will, when issued, represent approximately 16.5 per cent. of the Company's enlarged share capital. Following Admission, the Company will have 159,186,376 Ordinary Shares in issue.

Pursuant to the terms of the placing agreement, Arbuthnot, as agent for Imaginatik, has agreed to use its reasonable endeavours to place the Placing Shares with investors procured by it. The Placing is not underwritten. The Placing Price of 6 pence per Placing Share represents a discount of approximately 4 per cent. to the closing mid-market price of 6.25 pence per ordinary share on 7 August 2009, being the last dealing day prior to the date of this announcement.

The issue of the Placing Shares is conditional, amongst other things, on:

(i) admission to trading on AIM of the Placing Shares; and

(ii) the Placing Agreement not being terminated prior to Admission.

The Placing Agreement contains warranties given by the Company with respect to its business and certain matters connected with the Placing. In addition, the Company has given certain indemnities to Arbuthnot in connection with the Placing and Arbuthnot's performance of services in relation to the Placing.

Mark Turrell, CEO of Imaginatik, commented, "We are delighted to have secured this additional funding from new and existing investors. With the Placing oversubscribed, this is a very strong endorsement of the potential of Imaginatik, leaving us well positioned to pursue our growth strategy. Our pipeline continues to grow, which combined with our strong levels of recurring revenue, gives us confidence in our ability to capitalise on our market leading position." 

For further information, please contact:

Imaginatik plc
020 7917 2975
Mark Turrell, CEO
 
Shawn Taylor, CFO
 
 
 
Arbuthnot Securities Limited
020 7012 2000 
Tom Griffiths/Richard Johnson/
Niamh Corbett
 
 
 
ICIS
020 7651 8688
Caroline Evans-Jones/ Hilary Millar
 

About Imaginatik

Imaginatik is a leading provider of web-based enterprise collaboration software. Imaginatik's core software, Idea Central, is designed to help companies focus on idea generation towards strategic business objectives, and to share, develop and review those ideas across the organisation. Some of the world's largest organisations such as Merck, Dow, Chevron, General Electric and Cargill use Imaginatik's software, consulting and leading-edge research to enable their best-of-breed innovation, cost-reduction and process improvement activities.

Having been named as a World Economic Forum Technology Pioneer and a finalist for the IBM Lotus Awards in the Best Industry Solution category, Imaginatik's software and consulting services have helped clients discover significant sources of additional revenue, as well as tangible cost savings. Imaginatik is also committed to developing strategic solutions in the field of innovation, working with academic institutions such as the Hult Business School in Boston, and the Cass School of Business, London, as well as leading practitioners of corporate innovation.

For further information please visit http://www.imaginatik.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEUBVWRKNRWRAR
Date   Source Headline
15th Jun 20107:00 amRNSAppointment of Chief Operating Officer
1st Jun 20103:48 pmRNSHolding(s) in Company
13th May 20107:00 amRNSAppointment of Interim Vice President of Sales
6th May 20102:11 pmRNSHolding(s) in Company
28th Apr 20107:00 amRNSTrading Update
10th Mar 20107:00 amRNSDirector/PDMR Shareholding
4th Mar 20107:00 amRNSTrading Update
22nd Feb 20107:00 amRNSWindsor Foods Selects Imaginatik
17th Feb 20109:45 amRNSDirector Shareholding
29th Jan 201011:41 amRNSContract Win
22nd Dec 20097:00 amRNSDirectorate Change
17th Dec 20097:00 amRNSContract Win with Global Consumer Products Company
11th Dec 20097:00 amRNSContract Extension
17th Nov 20097:00 amRNSInterim Results
13th Nov 20097:00 amRNSContract Win
12th Nov 20097:00 amRNSNotice of Results
9th Oct 20097:00 amRNSTrading Update & Directorate Change
2nd Oct 20097:00 amRNSContract Win with global technology business
28th Sep 20097:00 amRNSContract Win with US Insurer
24th Sep 20097:00 amRNSDirector/PDMR Shareholding
23rd Sep 20097:00 amRNSProduct Launch
10th Sep 20097:00 amRNSContract Win
8th Sep 20097:00 amRNSWorld Economic Forum
13th Aug 20094:26 pmRNSHolding(s) in Company
13th Aug 20093:00 pmRNSHolding(s) in Company
13th Aug 200911:18 amRNSDirector/PDMR Shareholding
12th Aug 20095:17 pmRNSAdditional Listing
10th Aug 20097:00 amRNSPlacing
28th Jul 20097:00 amRNSAGM Statement
3rd Jul 20092:21 pmRNSDirector/PDMR - Share Subscription
29th Jun 20092:34 pmRNSAnnual Report & Accounts
17th Jun 20097:00 amRNSFinal Results
2nd Jun 20097:00 amRNSChange of Adviser & Notice of Results
15th May 200910:33 amRNSDirectorate Change
3rd Apr 20097:00 amRNSContract Win & Trading Update
19th Mar 20097:00 amRNSContract Extension with Chubb
5th Feb 20097:00 amRNSManagement Appointment
23rd Jan 20094:30 pmRNSDirector/PDMR Shareholding
23rd Jan 20097:00 amRNSWorld Economic Forum
15th Jan 20097:00 amRNSTrading on PLUS
14th Jan 20093:10 pmRNSDirector/PDMR Shareholding
14th Jan 20097:00 amRNSPharmaceutical Contract Win
9th Jan 20099:09 amRNSDirector/PDMR Shareholding
7th Jan 20091:35 pmRNSDirector/PDMR Shareholding
5th Jan 200911:10 amRNSDirector/PDMR Shareholding
5th Jan 20099:40 amRNSDirector/PDMR Shareholding
2nd Jan 20099:05 amRNSDirector/PDMR Shareholding
31st Dec 20087:00 amRNSDirector/PDMR Shareholding
31st Dec 20087:00 amRNSTotal Voting Rights
24th Dec 200810:48 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.